v3.26.1
Fair value of financial instruments (Tables)
 9 Months Ended
Mar. 27, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
The following table provides details of the financial instruments measured at fair value on a recurring basis, including:
Fair Value Measurements at Reporting Date Using
(in thousands)Level 1Level 2Level 3Total
As of March 27, 2026
Assets
Cash equivalents$— $129,730 $— $129,730 
Certificates of deposit and time deposits— 76,250 — 76,250 
Corporate debt securities— 212,238 — 212,238 
U.S. agency and U.S. treasury securities— 300,186 — 300,186 
Total$— $718,404 $— $718,404 
Liabilities
       Derivative liabilities – current portion$— $(10,835)
(1)
$— $(10,835)
Total$— $(10,835)$— $(10,835)

Fair Value Measurements at Reporting Date Using
(in thousands)Level 1Level 2Level 3Total
As of June 27, 2025
Assets
Cash equivalents$— $11,183 $— $11,183 
Certificates of deposit and time deposits— 145,752 — 145,752 
Corporate debt securities— 189,973 — 189,973 
U.S. agency and U.S. treasury securities— 292,094 — 292,094 
Derivative assets – current portion— 2,961 
(2)
— 2,961 
Total$— $641,963 $— $641,963 
Liabilities
       Derivative liabilities – current portion$— $(105)
(3)
$— $(105)
Total$— $(105)$— $(105)
(1)Foreign currency forward contracts with an aggregate notional amount of $253.0 million and 0.4 million Canadian dollars.
(2)Foreign currency forward contracts with an aggregate notional amount of $130.0 million and 0.5 million Canadian dollars.
(3)Foreign currency forward contracts with an aggregate notional amount of $35.0 million.
Schedule of Impacts of Derivative Gain (Loss) of Cash Flow Hedges
The following table provides a summary of the impact of derivative gain (loss) of the Company’s foreign currency forward contracts and interest rate swaps which were designated as cash flow hedges on the unaudited condensed consolidated statements of operations and other comprehensive income:
Three Months EndedNine Months Ended
(in thousands)Financial
statements
line item		March 27,
2026		March 28,
2025		March 27,
2026		March 28,
2025
Derivatives gain (loss) recognized in other comprehensive income (loss):
Foreign currency forward contractsOther
comprehensive
income (loss)		$(16,187)$1,505 $(13,678)$1,448 
Total derivatives gain (loss) recognized in other comprehensive income (loss)$(16,187)$1,505 $(13,678)$1,448 
Derivatives (gain) loss reclassified from accumulated other comprehensive income (loss) into earnings:
Foreign currency forward contractsCost of revenues$(3,399)$2,255 $(4,172)$(2,231)
Foreign currency forward contractsSG&A(257)176 (316)(169)
Foreign currency forward contractsForeign exchange gain (loss), net6,646 (1,963)7,707 1,970 
Total derivatives (gain) loss reclassified from accumulated other comprehensive income (loss) into earnings$2,990 $468 $3,219 $(430)
Change in net unrealized gain (loss) on derivatives instruments$(13,197)$1,973 $(10,459)$1,018 
Schedule of Derivative Financial Instruments
The following table provides the fair values of the Company’s derivative financial instruments for the periods presented:
March 27,
2026		June 27,
2025
(in thousands)Derivative
Assets		Derivative
Liabilities		Derivative
Assets		Derivative
Liabilities
Derivatives not designated as hedging instruments
Foreign currency forward and option contracts$— $(2,012)$1,303 $(12)
Derivatives designated as hedging instruments
Foreign currency forward contracts— (8,823)1,658 (93)
Derivatives, gross balances$— $(10,835)$2,961 $(105)
Schedule of Derivative Financial Instruments in the Unaudited Condensed Consolidated Balance Sheets
The Company recorded the fair value of derivative financial instruments in the unaudited condensed consolidated balance sheets as follows:
Derivative Financial InstrumentsBalance Sheet line item
Fair Value of Derivative AssetsOther current assets
Fair Value of Derivative LiabilitiesAccrued expenses